Clinical trials
Terminated Phase 2/3 Alzheimer Disease trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2017 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 2 |
| AstraZeneca | 1 |
| Boehringer Ingelheim | 1 |
| Janssen Research & Development, LLC | 1 |
| LeonaBio | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Neurim Pharmaceuticals Ltd. | 1 |
| University of South Florida | 1 |
| Washington University School of Medicine | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alzheimer Disease | 10 |
| Dementia | 4 |
| Brain Diseases | 1 |
| Central Nervous System Diseases | 1 |
| Mental Disorders | 1 |
| Nervous System Diseases | 1 |
| Neurocognitive Disorders | 1 |
| Tauopathies | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.